The clinical course and risk in patients with pseudo-Mahaim fibers

Lukasz Szumowski1, Robert Bodalski, Zbigniew Jedynak

  • 1Institute of Cardiology, Warszawa Anin, Poland. lszumowski@ikard.pl

Cardiology Journal
|August 14, 2008
PubMed
Abstract

Insights

Pseudo-Mahaim (AP-M) fibers, a rare accessory pathway variant, are associated with various arrhythmias including AV nodal reentrant tachycardia. Many patients with AP-M exhibit dual atrioventricular node pathways, increasing arrhythmia risk.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Arrhythmias

Background:

  • Pseudo-Mahaim (AP-M) fibers represent a rare variant of atrioventricular (AV) accessory pathways.
  • These pathways exhibit slow conduction and decremental properties, predisposing to arrhythmias.
  • Dual physiological AV node pathways (slow and fast) are frequently observed in patients with AP-M.

Purpose of the Study:

  • To analyze the occurrence of various arrhythmias in patients with AP-M.
  • To investigate the correlation between dual AV node properties and arrhythmia development in AP-M patients.
  • To characterize the anatomical location and clinical presentation of AP-M.

Main Methods:

  • Retrospective analysis of 27 patients (14-53 years) diagnosed with AP-M.
  • Evaluation of clinical course, focusing on arrhythmia occurrence.
  • Comparison of patients with dual AV node properties versus those with fast pathway only.

Main Results:

  • Dual AV node properties were present in 18 patients (Group 1); 9 had fast pathway only (Group 2).
  • Atrioventricular reentrant tachycardia (AVRT) was the most common arrhythmia (26 patients).
  • Other observed arrhythmias included AV nodal reentrant tachycardia (AVNRT), atrial fibrillation (AF), atrial flutter (AFL), and ventricular fibrillation (VF).

Conclusions:

  • The majority of AP-M pathways were right-sided.
  • Two-thirds of AP-M patients possessed the anatomical substrate for AVNRT.
  • Ventricular fibrillation or asystole occurred in approximately 10% of patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...